324 related articles for article (PubMed ID: 25195116)
1. [Postoperative radiotherapy of prostate cancer].
Guérif S; Latorzeff I; Lagrange JL; Hennequin C; Supiot S; Garcia A; François P; Soulié M; Richaud P; Salomon L
Cancer Radiother; 2014 Oct; 18(5-6):517-23. PubMed ID: 25195116
[TBL] [Abstract][Full Text] [Related]
2. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
3. [Postoperative radiotherapy of prostate cancer].
Richaud P; Sargos P; Henriques de Figueiredo B; Latorzeff I; Mongiat-Artus P; Houédé N; Salomon L; Wallerand H
Cancer Radiother; 2010 Oct; 14(6-7):500-3. PubMed ID: 20810300
[TBL] [Abstract][Full Text] [Related]
4. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S
Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475
[TBL] [Abstract][Full Text] [Related]
5. [Postoperative radiotherapy for prostate cancer: when to propose it? What is the place for androgen deprivation?].
Benziane-Ouaritini N; Sargos P; Beauval JB; Supiot S; Latorzeff I
Cancer Radiother; 2021 Oct; 25(6-7):667-673. PubMed ID: 34391651
[TBL] [Abstract][Full Text] [Related]
6. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Sargos P; Chabaud S; Latorzeff I; Magné N; Benyoucef A; Supiot S; Pasquier D; Abdiche MS; Gilliot O; Graff-Cailleaud P; Silva M; Bergerot P; Baumann P; Belkacemi Y; Azria D; Brihoum M; Soulié M; Richaud P
Lancet Oncol; 2020 Oct; 21(10):1341-1352. PubMed ID: 33002438
[TBL] [Abstract][Full Text] [Related]
8. [Post-prostatectomy radiotherapy: for which patients and when?].
Hennequin C; Ravery V; Maylin C; Boccon-Gibbod L
Cancer Radiother; 2002 May; 6(3):168-74. PubMed ID: 12116842
[TBL] [Abstract][Full Text] [Related]
9. [Salvage radiotherapy after prostatectomy - what do do in case of elevated post operative PSA or macroscopic relapse?].
Latorzeff I; Ploussard G; Schick U; Benziane N; Pasquier D; Sargos P
Cancer Radiother; 2021 Dec; 25(8):822-829. PubMed ID: 34702645
[TBL] [Abstract][Full Text] [Related]
10. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Carrie C; Magné N; Burban-Provost P; Sargos P; Latorzeff I; Lagrange JL; Supiot S; Belkacemi Y; Peiffert D; Allouache N; Dubray BM; Servagi-Vernat S; Suchaud JP; Crehange G; Guerif S; Brihoum M; Barbier N; Graff-Cailleaud P; Ruffion A; Dussart S; Ferlay C; Chabaud S
Lancet Oncol; 2019 Dec; 20(12):1740-1749. PubMed ID: 31629656
[TBL] [Abstract][Full Text] [Related]
11. A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.
Ost P; De Troyer B; Fonteyne V; Oosterlinck W; De Meerleer G
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1316-22. PubMed ID: 20675081
[TBL] [Abstract][Full Text] [Related]
12. [Prostate cancer: doses and volumes of radiotherapy].
Hennequin C; Rivera S; Quero L; Latorzeff I
Cancer Radiother; 2010 Oct; 14(6-7):474-8. PubMed ID: 20728390
[TBL] [Abstract][Full Text] [Related]
13. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
14. [Prostate cancer external beam radiotherapy].
de Crevoisier R; Pommier P; Latorzeff I; Chapet O; Chauvet B; Hennequin C
Cancer Radiother; 2016 Sep; 20 Suppl():S200-9. PubMed ID: 27516051
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant and salvage radiotherapy after radical prostatectomy.
Höcht S; Wiegel T; Schostak M; Hinkelbein W
Onkologie; 2002 Jun; 25(3):201-6. PubMed ID: 12119453
[TBL] [Abstract][Full Text] [Related]
16. [Salvage radiotherapy in rising PSA after radical prostatectomy].
Carrie C; Pommier P
Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy in prostate cancer: Dose and volumes.
Schick U; Latorzeff I; Sargos P
Cancer Radiother; 2021 Oct; 25(6-7):674-678. PubMed ID: 34400088
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy after radical prostatectomy: immediate or early delayed?
Bottke D; Bartkowiak D; Schrader M; Wiegel T
Strahlenther Onkol; 2012 Dec; 188(12):1096-101. PubMed ID: 23128897
[TBL] [Abstract][Full Text] [Related]
20. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J
Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
